Arrowstreet Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.8M | Sell |
|
|||||
|
2025
Q1 | $264M | Buy |
|
|||||
|
2024
Q4 | $73.2M | Buy |
|
|||||
|
2024
Q3 | $34.6M | Buy |
|
|||||
|
2024
Q2 | $20.4M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.78M | Sell |
|
|||||
|
2023
Q3 | $95.4M | Sell |
|
|||||
|
2023
Q2 | $228M | Sell |
|
|||||
|
2023
Q1 | $337M | Buy |
|
|||||
|
2022
Q4 | $266M | Buy |
|
|||||
|
2022
Q3 | $9.43M | Sell |
|
|||||
|
2022
Q2 | $238M | Sell |
|
|||||
|
2022
Q1 | $272M | Buy |
|
|||||
|
2021
Q4 | $47M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $19M | Sell |
|
|||||
|
2021
Q1 | $159M | Sell |
|
|||||
|
2020
Q4 | $390M | Buy |
|
|||||
|
2020
Q3 | $409M | Sell |
|
|||||
|
2020
Q2 | $429M | Buy |
|
|||||
|
2020
Q1 | $243M | Sell |
|
|||||
|
2019
Q4 | $430M | Buy |
|
|||||
|
2019
Q3 | $383M | Sell |
|
|||||
|
2019
Q2 | $387M | Sell |
|
|||||
|
2019
Q1 | $504M | Buy |
|
|||||
|
2018
Q4 | $445M | Buy |
|
|||||
|
2018
Q3 | $224M | Buy |
|
|||||
|
2018
Q2 | $53.4M | Buy |
|
|||||
|
2018
Q1 | $2.37M | Sell |
|
|||||
|
2017
Q4 | $25.5M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $177M | Sell |
|
|||||
|
2017
Q1 | $210M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $53.2M | Sell |
|
|||||
|
2016
Q2 | $245M | Buy |
|
|||||
|
2016
Q1 | $112M | Buy |
|
|||||
|
2015
Q4 | $33.1M | Sell |
|
|||||
|
2015
Q3 | $73.7M | Buy |
|
|||||
|
2015
Q2 | $30.9M | Buy |
|
|||||
|
2015
Q1 | $8.62M | Sell |
|
|||||
|
2014
Q4 | $320M | Buy |
|
|||||
|
2014
Q3 | $313M | Buy |
|
|||||
|
2014
Q2 | $236M | Sell |
|
|||||
|
2014
Q1 | $290M | Buy |
|
|||||
|
2013
Q4 | $148M | Sell |
|
|||||
|
2013
Q3 | $164M | Sell |
|
|||||
|
2013
Q2 | $291M | Buy |
|